117 related articles for article (PubMed ID: 29331723)
21. Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development.
Aupperlee MD; Smith KT; Kariagina A; Haslam SZ
Endocrinology; 2005 Aug; 146(8):3577-88. PubMed ID: 15878961
[TBL] [Abstract][Full Text] [Related]
22. p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization.
Khan JA; Amazit L; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
Mol Endocrinol; 2011 Oct; 25(10):1710-24. PubMed ID: 21816898
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.
Pierson-Mullany LK; Lange CA
Mol Cell Biol; 2004 Dec; 24(24):10542-57. PubMed ID: 15572662
[TBL] [Abstract][Full Text] [Related]
24. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
25. Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes.
Bellance C; Khan JA; Meduri G; Guiochon-Mantel A; Lombès M; Loosfelt H
Mol Biol Cell; 2013 May; 24(9):1363-74. PubMed ID: 23485561
[TBL] [Abstract][Full Text] [Related]
26. Distinct molecular pathways mediate progesterone-induced growth inhibition and focal adhesion.
Lin VC; Woon CT; Aw SE; Guo C
Endocrinology; 2003 Dec; 144(12):5650-7. PubMed ID: 12970168
[TBL] [Abstract][Full Text] [Related]
27. Expression of progesterone receptor B is associated with G0/G1 arrest of the cell cycle and growth inhibition in NIH3T3 cells.
Horiuchi S; Kato K; Suga S; Takahashi A; Ueoka Y; Arima T; Nishida J; Hachisuga T; Kawarabayashi T; Wake N
Exp Cell Res; 2005 May; 305(2):233-43. PubMed ID: 15817149
[TBL] [Abstract][Full Text] [Related]
28. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.
Panigone S; Debernardi S; Taya Y; Fontanella E; Airoldi R; Delia D
Oncogene; 2000 Aug; 19(35):4035-41. PubMed ID: 10962560
[TBL] [Abstract][Full Text] [Related]
29. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
[TBL] [Abstract][Full Text] [Related]
30. Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms.
Zitzmann K; Vlotides G; Brand S; Lahm H; Spöttl G; Göke B; Auernhammer CJ
Endocr Relat Cancer; 2012 Jun; 19(3):423-34. PubMed ID: 22499437
[TBL] [Abstract][Full Text] [Related]
31. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis.
Mote PA; Bartow S; Tran N; Clarke CL
Breast Cancer Res Treat; 2002 Mar; 72(2):163-72. PubMed ID: 12038707
[TBL] [Abstract][Full Text] [Related]
32. Effect of initial subcellular localization of progesterone receptor on import kinetics and transcriptional activity.
Li H; Fidler ML; Lim CS
Mol Pharm; 2005; 2(6):509-18. PubMed ID: 16323958
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
34. Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator.
Narayanan R; Adigun AA; Edwards DP; Weigel NL
Mol Cell Biol; 2005 Jan; 25(1):264-77. PubMed ID: 15601848
[TBL] [Abstract][Full Text] [Related]
35. Regulation of progesterone receptor activity by cyclin dependent kinases 1 and 2 occurs in part by phosphorylation of the SRC-1 carboxyl-terminus.
Moore NL; Weigel NL
Int J Biochem Cell Biol; 2011 Aug; 43(8):1157-67. PubMed ID: 21550420
[TBL] [Abstract][Full Text] [Related]
36. Detection of progesterone receptor forms A and B by immunohistochemical analysis.
Mote PA; Johnston JF; Manninen T; Tuohimaa P; Clarke CL
J Clin Pathol; 2001 Aug; 54(8):624-30. PubMed ID: 11477119
[TBL] [Abstract][Full Text] [Related]
37. Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients.
Pathiraja TN; Shetty PB; Jelinek J; He R; Hartmaier R; Margossian AL; Hilsenbeck SG; Issa JP; Oesterreich S
Clin Cancer Res; 2011 Jun; 17(12):4177-86. PubMed ID: 21459801
[TBL] [Abstract][Full Text] [Related]
38. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).
Groshong SD; Owen GI; Grimison B; Schauer IE; Todd MC; Langan TA; Sclafani RA; Lange CA; Horwitz KB
Mol Endocrinol; 1997 Oct; 11(11):1593-607. PubMed ID: 9328342
[TBL] [Abstract][Full Text] [Related]
39. A novel retinoid-related molecule inhibits pancreatic cancer cell proliferation by a retinoid receptor independent mechanism via suppression of cell cycle regulatory protein function and induction of caspase-associated apoptosis.
Balasubramanian S; Chandraratna RA; Eckert RL
Oncogene; 2005 Jun; 24(26):4257-70. PubMed ID: 15856029
[TBL] [Abstract][Full Text] [Related]
40. Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines.
Smid-Koopman E; Blok LJ; Kühne LC; Burger CW; Helmerhorst TJ; Brinkmann AO; Huikeshoven FJ
J Soc Gynecol Investig; 2003 Jan; 10(1):49-57. PubMed ID: 12517594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
